Cellyan gets 180-day Nasdaq extension to meet bid price rule Jul 16, 2026 04:30PM
Cellyan Biotechnology receives Nasdaq bid price deficiency notice Jan 16, 2026 04:31PM
Cellyan Biotechnology receives Nasdaq bid price deficiency notice Jan 16, 2026 04:31PM
DCS Announces Q3 2025 Quarterly Financial Statements Dec 1, 2025 08:30AM